000			02008 a2200661 4500
005			20250517063652.0
264		0	_c20160915
008			201609s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2015.319 _2doi
040			_aNLM _beng _cNLM
100	1		_aKordes, M
245	0	0	_aCooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling. _h[electronic resource]
260			_bLeukemia _cApr 2016
300			_a937-46 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aBlotting, Western
650	0	4	_aCells, Cultured
650	0	4	_aEmbryo, Mammalian _xcytology
650	0	4	_aExome _xgenetics
650	0	4	_aFibroblasts _xcytology
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHigh-Throughput Nucleotide Sequencing
650	0	4	_aHistiocytic Sarcoma _xgenetics
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMutation _xgenetics
650	0	4	_aNeoplasm Staging
650	0	4	_aPrognosis
650	0	4	_aProto-Oncogene Proteins B-raf _xgenetics
650	0	4	_aProto-Oncogene Proteins p21(ras) _xgenetics
650	0	4	_aSignal Transduction
700	1		_aRöring, M
700	1		_aHeining, C
700	1		_aBraun, S
700	1		_aHutter, B
700	1		_aRichter, D
700	1		_aGeörg, C
700	1		_aScholl, C
700	1		_aGröschel, S
700	1		_aRoth, W
700	1		_aRosenwald, A
700	1		_aGeissinger, E
700	1		_avon Kalle, C
700	1		_aJäger, D
700	1		_aBrors, B
700	1		_aWeichert, W
700	1		_aGrüllich, C
700	1		_aGlimm, H
700	1		_aBrummer, T
700	1		_aFröhling, S
773	0		_tLeukemia _gvol. 30 _gno. 4 _gp. 937-46
856	4	0	_uhttps://doi.org/10.1038/leu.2015.319 _zAvailable from publisher's website
999			_c25461977 _d25461977